Addus HomeCare (NASDAQ:ADUS) Announces Earnings Results

Addus HomeCare (NASDAQ:ADUS) issued its earnings results on Monday. The company reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.53 by $0.03, Briefing.com reports. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $362.30 million for the quarter, compared to analysts’ expectations of $354.48 million. During the same quarter in the previous year, the firm posted $1.30 EPS. The business’s revenue for the quarter was up 25.0% compared to the same quarter last year.

Addus HomeCare Stock Up 4.3%

Shares of NASDAQ:ADUS opened at $117.05 on Wednesday. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72. The firm has a fifty day moving average of $115.28 and a 200 day moving average of $112.41. The firm has a market capitalization of $2.16 billion, a PE ratio of 25.67, a price-to-earnings-growth ratio of 1.87 and a beta of 0.86. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.74 and a current ratio of 1.74.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares in the company, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the transaction, the director owned 5,067 shares of the company’s stock, valued at $582,350.31. This trade represents a 23.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 34,310 shares of company stock worth $3,958,375. Corporate insiders own 4.50% of the company’s stock.

Institutional Trading of Addus HomeCare

Hedge funds have recently added to or reduced their stakes in the business. State of Wyoming bought a new stake in Addus HomeCare in the second quarter worth $47,000. Raymond James Financial Inc. bought a new stake in Addus HomeCare in the second quarter worth $61,000. EverSource Wealth Advisors LLC lifted its stake in Addus HomeCare by 560.0% in the second quarter. EverSource Wealth Advisors LLC now owns 561 shares of the company’s stock worth $65,000 after purchasing an additional 476 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Addus HomeCare by 299.7% in the second quarter. Tower Research Capital LLC TRC now owns 1,563 shares of the company’s stock worth $180,000 after purchasing an additional 1,172 shares during the last quarter. Finally, Captrust Financial Advisors bought a new stake in Addus HomeCare in the second quarter worth $207,000. 95.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ADUS. Royal Bank Of Canada boosted their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the company an “outperform” rating in a report on Friday, August 22nd. Barclays boosted their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a report on Tuesday. Stephens reissued an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a report on Wednesday, September 3rd. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, October 8th. Finally, TD Cowen boosted their price target on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $138.50.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.